PLEASANTON, Calif., July 21, 2021 /PRNewswire/ — Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases, today announced it has secured gross proceeds of approximately…
